微创介入类医疗器械
Search documents
北交所周报:9家公司提交上市申请,28家公司申报在即
Sou Hu Cai Jing· 2025-12-31 20:33
Summary of Key Points Core Viewpoint The Beijing Stock Exchange (BSE) has seen a decrease in trading volume and value over the past week, with a total of 287 listed companies as of December 21, 2025. The market is also witnessing new listings and applications for IPOs, indicating ongoing activity despite the recent declines in trading metrics. Trading Metrics - As of December 21, 2025, the BSE has 287 listed companies with a total share capital of 39.676 billion shares and a circulating share capital of 25.312 billion shares [2] - For the week of December 22-27, 2025, the trading volume was 4.634 billion shares, a decrease of 6.63% week-over-week [3] - The trading value for the same week was 99.934 billion yuan, down 11.68% from the previous week [3] - The average trading price was 21.57 yuan, reflecting a decrease of 5.41% [3] - The BSE 50 Index fell by 1.19% to 1463.04 points, with 28 stocks rising and 22 falling [3] New Listings and IPO Applications - During the week of December 22-27, 2025, one company was listed, and one company opened for subscription [6][12] - A total of 9 companies had their IPO applications accepted, while 4 companies passed the review process [6][38] - As of December 27, 2025, there are 160 companies awaiting review, with 13 accepted, 121 under inquiry, and 14 submitted for registration [6] Recent IPOs - Jiangtian Technology (江天科技) was listed on December 25, 2025, becoming the 287th company on the BSE, with a first-day closing price of 47.85 yuan, up 180.58% from its issue price [8][9] - The company aims to raise 531 million yuan for the construction of a comprehensive R&D and manufacturing base [9] - For the first three quarters of 2025, Jiangtian Technology reported a revenue of 468 million yuan, a year-on-year increase of 10.85%, and a net profit of 89.11 million yuan, up 11.45% [11] Upcoming IPOs - Hengtong Optoelectronics (蘅东光) opened for subscription on December 23, 2025, with a target of raising 323.8 million yuan [13] - The company reported a revenue of 1.315 billion yuan for 2024, a significant increase of 91.38% year-on-year, and a net profit of 224 million yuan, up 123.75% [16] - Other companies, including Miro Technology (觅容科技) and Meiya Technology (美亚科技), have submitted registration applications, aiming to raise 314 million yuan and 200 million yuan, respectively [19][22] Companies Passing Review - Four companies passed the listing committee review during the week, including Ying's Holdings (英氏控股) and Longyuan Co., Ltd. (隆源股份) [24][26] - Ying's Holdings reported revenues of 1.974 billion yuan for 2024, with a net profit of 210 million yuan [25] - Longyuan Co., Ltd. aims to raise 560 million yuan for projects related to new energy systems [28] Companies Completing Counseling - A total of 28 companies completed their counseling work during the week [68] - These companies are preparing for their IPOs, indicating a robust pipeline for future listings on the BSE [68]
刚刚!IPO审4过4
梧桐树下V· 2025-12-26 16:04
文/梧桐数据中心 12月26日,IPO共审核4家公司(深主板、创业板各1家,北交所2家),4家均获通过。 | 深主板 | | | | | | | --- | --- | --- | --- | --- | --- | | 公司简称 | 主营业务 | 2024年营收 | 2024年净利润 | 审核结果 | 保荐/律所/审计 | | 生态环保面料的研发、生 | 福恩股份 | 181,282.69 | 25.475.49 | 通过 | 中信证券/国浩(杭州)/ | | 产和销售 | | | | | 天健 | | 创业板 | | | | | | | 公司简称 | 主营业务 | 2024年营收 | 2024年净利润 | 审核结果 | 保荐/律所/审计 | | 无人机电动动力系统及机 | 三瑞智能 器人动力系统的研发、生 | 83,147.85 | 32,050.83 | 通过 | 国泰海通/ 上海方达/立信 | | 产和销售 | | | | | | | 北交所 | | | | | | | 公司简称 | 主营业务 | 2024年营收 | 2024年净利润 | 审核结果 | 保荐/律所/审计 | | 功能性高分子发泡材料的 ...
下周审核9家IPO,创业板开板以来首单未盈利IPO项目将上会迎审!
Sou Hu Cai Jing· 2025-12-21 13:26
Group 1 - A total of 9 companies are scheduled for IPO review next week, aiming to raise a combined capital of 9.111 billion yuan [1] - The companies include Ying's Holdings, Shenglong Co., Shiya Technology, and others, with various industries represented such as food manufacturing, non-ferrous metal mining, and electronic equipment manufacturing [2][6] - Ying's Holdings is a leading enterprise in the infant food industry in China, focusing on nutritional care for infants and young children [6][7] Group 2 - Shenglong Co. is a major molybdenum company in China, engaged in the comprehensive development and utilization of non-ferrous metal resources [15][16] - Shiya Technology specializes in micro-display solutions, being the first to achieve mass production of silicon-based OLED micro-displays [10][11] - Dapu Microelectronics focuses on enterprise-level SSD products, with a strong capability in self-research and development [20][21] Group 3 - Longyuan Co. specializes in the research, production, and sales of aluminum alloy precision die-casting parts, primarily for the automotive industry [25][26] - Fuen Co. is a global supplier of eco-friendly fabrics, emphasizing sustainable development in its operations [33] - Sanrui Intelligent Technology is a leading manufacturer of drone and robot power systems, actively developing products for electric vertical takeoff and landing aircraft [29][30]
普昂医疗完成IPO辅导:董事长胡超宇夫妇控股59%,妻子毛柳莺曾有7年未就业
Sou Hu Cai Jing· 2025-06-05 01:53
Core Viewpoint - Puang Medical Technology Co., Ltd. is preparing for an IPO on the Beijing Stock Exchange, having completed its guidance work with Guojin Securities as the advisory institution [2]. Financial Performance - In 2024, Puang Medical achieved operating revenue of 318.03 million yuan, representing a year-on-year increase of 34.61% [3]. - The net profit for the same period was 64.88 million yuan, up 41.34% compared to the previous year [3]. - The gross profit margin improved to 49.44%, compared to 47.20% in the previous year [3]. Shareholding Structure - The legal representative and chairman, Hu Chaoyu, directly holds 42,079 shares (0.10%) and indirectly controls 28.54% of the voting rights through Taiyouhong, 26.13% through Pumao Partnership, and 4.72% through Hangzhou Youying [4]. - Hu Chaoyu and his spouse, Mao Liuying, collectively control 59.49% of the voting rights, making them the actual controllers of the company [4]. Company Background - Puang Medical was established in January 2013, focusing on the research, production, and sales of diabetes care, general drug infusion, and minimally invasive medical devices [2]. - The registered capital of the company is 42.33 million yuan [2].